Literature DB >> 9397406

Lipid specificity and location of the sterol carrier protein-2 fatty acid-binding site: a fluorescence displacement and energy transfer study.

A Frolov1, K Miller, J T Billheimer, T H Cho, F Schroeder.   

Abstract

Although it was recently recognized that sterol carrier protein-2 (SCP-2) interacts with fatty acids, little is known regarding the specificity of SCP-2 for long-chain fatty acids or branched-chain fatty-acid-like molecules. Likewise the location of the fatty-acid binding site within SCP-2 is unresolved. A fluorescent cis-parinaric acid displacement assay was used to show that SCP-2 optimally interacted with 14-22 carbon chain lipidic molecules: polyunsaturated fatty acids > monounsaturated, saturated > branched-chain isoprenoids > branched-chain phytol-derived fatty acids. In contrast, the other major fatty-acid binding protein in liver, fatty-acid binding protein (L-FABP), displayed a much narrower carbon chain preference in general: polyunsaturated fatty acids > branched-chain phytol-derived fatty acids > 14- and 16-carbon saturated > branched-chain isoprenoids. However, both SCP-2 and L-FABP displayed a very similar unsaturated fatty-acid specificity profile. The presence and location of the SCP-2 lipid binding site were investigated by fluorescence energy transfer. The distance between the SCP-2 Trp50 and bound cis-parinaric acid was determined to be 40 A. Thus, the SCP-2 fatty-acid binding site appeared to be located on the opposite side of the SCP-2 Trp50. These findings not only contribute to our understanding of the SCP-2 ligand binding site but also provide evidence suggesting a potential role for SCP-2 and/or L-FABP in metabolism of branched-chain fatty acids and isoprenoids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397406     DOI: 10.1007/s11745-997-0154-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  57 in total

1.  Involvement of sterol carrier protein-2 in dolichol biosynthesis.

Authors:  J Ericsson; T J Scallen; T Chojnacki; G Dallner
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

2.  The sterol carrier protein-2 fatty acid binding site: an NMR, circular dichroic, and fluorescence spectroscopic determination.

Authors:  N J Stolowich; A Frolov; B Atshaves; E J Murphy; C A Jolly; J T Billheimer; A I Scott; F Schroeder
Journal:  Biochemistry       Date:  1997-02-18       Impact factor: 3.162

Review 3.  Acyl-CoA binding proteins: multiplicity and function.

Authors:  R E Gossett; A A Frolov; J B Roths; W D Behnke; A B Kier; F Schroeder
Journal:  Lipids       Date:  1996-09       Impact factor: 1.880

4.  Sterol carrier protein-2 mediated cholesterol esterification in transfected L-cell fibroblasts.

Authors:  E J Murphy; F Schroeder
Journal:  Biochim Biophys Acta       Date:  1997-04-21

5.  Sterol domains in phospholipid membranes: dehydroergosterol polarization measures molecular sterol transfer.

Authors:  P Butko; I Hapala; G Nemecz; F Schroeder
Journal:  J Biochem Biophys Methods       Date:  1992-03

6.  Spontaneous and protein-mediated sterol transfer between intracellular membranes.

Authors:  A Frolov; J K Woodford; E J Murphy; J T Billheimer; F Schroeder
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

7.  Structure-activity studies of human sterol carrier protein 2.

Authors:  U Seedorf; S Scheek; T Engel; C Steif; H J Hinz; G Assmann
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

8.  Interaction of fluorescent delta 5,7,9(11),22-ergostatetraen-3 beta-ol with sterol carrier protein-2.

Authors:  F Schroeder; P Butko; G Nemecz; T J Scallen
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

9.  Sterol carrier protein2. Delivery of cholesterol from adrenal lipid droplets to mitochondria for pregnenolone synthesis.

Authors:  R Chanderbhan; B J Noland; T J Scallen; G V Vahouny
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

10.  NMR determination of the secondary structure and the three-dimensional polypeptide backbone fold of the human sterol carrier protein 2.

Authors:  T Szyperski; S Scheek; J Johansson; G Assmann; U Seedorf; K Wüthrich
Journal:  FEBS Lett       Date:  1993-11-29       Impact factor: 4.124

View more
  23 in total

1.  Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells.

Authors:  F Schroeder; B P Atshaves; O Starodub; A L Boedeker; R R Smith; J B Roths; W B Foxworth; A B Kier
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-04       Impact factor: 4.698

3.  Sterol carrier protein-2 suppresses microsomal acyl-CoA hydrolysis.

Authors:  C A Jolly; H Chao; A B Kier; J T Billheimer; F Schroeder
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

4.  FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.

Authors:  Huan Huang; Avery L McIntosh; Gregory G Martin; Danilo Landrock; Sarah Chung; Kerstin K Landrock; Lawrence J Dangott; Shengrong Li; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2016-09-02       Impact factor: 3.162

5.  Interaction of the N-terminus of sterol carrier protein 2 with membranes: role of membrane curvature.

Authors:  H Huang; J M Ball; J T Billheimer; F Schroeder
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

6.  Impact of SCP-2/SCP-x gene ablation and dietary cholesterol on hepatic lipid accumulation.

Authors:  Devon Klipsic; Danilo Landrock; Gregory G Martin; Avery L McIntosh; Kerstin K Landrock; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-25       Impact factor: 4.052

7.  Effects of lovastatin on breast cancer cells: a proteo-metabonomic study.

Authors:  Jelena Klawitter; Touraj Shokati; Vanessa Moll; Uwe Christians; Jost Klawitter
Journal:  Breast Cancer Res       Date:  2010-03-05       Impact factor: 6.466

8.  The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.

Authors:  Gregory G Martin; Avery L McIntosh; Huan Huang; Shipra Gupta; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2013-12-10       Impact factor: 3.162

9.  Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels.

Authors:  Gregory G Martin; Sarah Chung; Danilo Landrock; Kerstin K Landrock; Lawrence J Dangott; Xiaoxue Peng; Martin Kaczocha; Eric J Murphy; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2016-07-23       Impact factor: 1.880

10.  Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism.

Authors:  Barbara P Atshaves; Stephen M Storey; Huan Huang; Friedhelm Schroeder
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.